Development of immunization trials against Pasteurella multocida

70Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Pasteurellosis is one of the most important respiratory diseases facing economically valuable farm animals such as poultry, rabbit, cattle, goats and pigs. It causes severe economic loss due to its symptoms that range from primary local infection to fatal septicemia. Pasteurella multocida is the responsible pathogen for this contagious disease. Chemotherapeutic treatment of Pasteurella is expensive, lengthy, and ineffective due to the increasing antibiotics resistance of the bacterium, as well as its toxicity to human consumers. Though, biosecurity measures played a role in diminishing the spread of the pathogen, the immunization methods were always the most potent preventive measures. Since the early 1950s, several trials for constructing and formulating effective vaccines were followed. This up-to-date review classifies and documents such trials. A section is devoted to discussing each group benefits and defects. © 2013 Elsevier Ltd.

Cite

CITATION STYLE

APA

Ahmad, T. A., Rammah, S. S., Sheweita, S. A., Haroun, M., & El-Sayed, L. H. (2014, February 12). Development of immunization trials against Pasteurella multocida. Vaccine. Elsevier Ltd. https://doi.org/10.1016/j.vaccine.2013.11.068

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free